The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma
Open Access
- 8 July 2008
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 99 (2) , 364-370
Abstract
Mutations in two genes encoding cell cycle regulatory proteins have been shown to cause familial cutaneous malignant melanoma (CMM). About 20% of melanoma-prone families bear a point mutation in the CDKN2A locus at 9p21, which encodes two unrelated proteins, p16INK4a and p14ARF. Rare mutations in CDK4 have also been linked to the disease. Although the CDKN2A gene has been shown to be the major melanoma predisposing gene, there remains a significant proportion of melanoma kindreds linked to 9p21 in which germline mutations of CDKN2A have not been identified through direct exon sequencing. The purpose of this study was to assess the contribution of large rearrangements in CDKN2A to the disease in melanoma-prone families using multiplex ligation-dependent probe amplification. We examined 214 patients from independent pedigrees with at least two CMM cases. All had been tested for CDKN2A and CDK4 point mutation, and 47 were found positive. Among the remaining 167 negative patients, one carried a novel genomic deletion of CDKN2A exon 2. Overall, genomic deletions represented 2.1% of total mutations in this series (1 of 48), confirming that they explain a very small proportion of CMM susceptibility. In addition, we excluded a new gene on 9p21, KLHL9, as being a major CMM gene.Keywords
This publication has 48 references indexed in Scilit:
- Functional, structural, and genetic evaluation of 20CDKN2Agerm line mutations identified in melanoma-prone families or patientsHuman Mutation, 2009
- Novel CDKN2A Mutations Detected in Western Swedish Families with Hereditary Malignant MelanomaJournal of Investigative Dermatology, 2007
- New founder germline mutations of CDKN2A in melanoma‐prone families and multiple primary melanoma development in a patient receiving levodopa treatmentGenes, Chromosomes and Cancer, 2007
- Prevalence of 9p21 deletions in UK melanoma familiesGenes, Chromosomes and Cancer, 2005
- Germline mutation and large deletion analysis of the CDKN2A and ARF genes in families with multiple melanoma or an aggregation of malignant melanoma and breast cancerInternational Journal of Cancer, 2004
- A single Mediterranean, possibly Jewish, origin for the Val59Gly CDKN2A mutation in four melanoma-prone familiesEuropean Journal of Human Genetics, 2003
- Familial and Attributable Risks in Cutaneous Melanoma: Effects of Proband and AgeJournal of Investigative Dermatology, 2003
- Rapid detection of novelBRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragmentsHuman Mutation, 2002
- Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group [published erratum appears in Hum Mol Genet 1998 May;7(5):941]Human Molecular Genetics, 1998
- Systematic Population-Based Assessment of Cancer Risk in First-Degree Relatives of Cancer ProbandsJNCI: Journal of the National Cancer Institute, 1994